Showing 1 - 17 results of 17 for search 'M. V. Antonyuk', query time: 0.03s
Refine Results
-
1
DYSLIPIDEMIA ROLE IN THE DEVELOPMENT OF METABOLIC SYNDROME by M. V. Antonyuk, V. V. Knyshova
Published 2011-10-01
Article -
2
-
3
Atorvastatin therapy and antioxidant status correction in patients with metabolic syndrome by N. S. Yubitskaya, M. V. Antonyuk, V. I. Yankova
Published 2013-06-01
Article -
4
Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment by E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk
Published 2019-12-01
Article -
5
IMMUNE AND METABOLIC PHENOTYPES OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN MEN by E. P. Kalinina, E. G. Lobanova, M. V. Antonyuk
Published 2014-08-01
Article -
6
-
7
-
8
Polyunsaturated fatty acid status of leukocyte membranes in COPD patients by Yu. K. Denisenko, T. P. Novgorodtseva, V. V. Knyshova, M. V. Antonyuk
Published 2021-03-01
Article -
9
-
10
Prevalence and biomarkers in metabolic syndrome by O. Y. Kytikova, M. V. Antonyuk, T. A. Kantur, T. P. Novgorodtseva, Y. K. Denisenko
Published 2021-10-01
Article -
11
IMMUNE MECHANISMS FOR DEVELOPMENT OF CONTROLLED AND PARTIALLY CONTROLLED ASTHMA by T. I. Vitkina, T. P. Novgorodtseva, E. P. Kalinina, E. G. Lobanova, M. V. Antonyuk
Published 2019-07-01
Article -
12
-
13
-
14
-
15
-
16
DEREALIZATION DISORDERS IN EPILEPSY by P. N. Vlasov, A. V. Chervyakov, G. R. Drozzhina, M. V. Antonyuk, N. V. Orekhova, V. V. Gnezditsky, T. Yu. Noskova, P. A. Fedin
Published 2016-08-01
Article -
17
The efficacy and safety of valproic acid medications with controlled active ingredient release in adults in real clinical practice from the position of pharmacokinetic and pharmaco... by P. N. Vlasov, N. V. Orekhova, M. V. Antonyuk, N. V. Filatova, N. A. Schnaider, D. V. Dmitrenko, S. N. Zobova, I. E. Poverennova, A. V. Yakunina, V. A. Kalinin, S. K. Zyryanov, I. F. Tishchenkova
Published 2017-06-01
Article